Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08877 | Ruxolitinib | 1 / 2 | Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08877 | Ruxolitinib | 1 / 2 | Recruiting | 1 |